Biology Direct (Nov 2021)

The p53 family member p73 in the regulation of cell stress response

  • Julian M. Rozenberg,
  • Svetlana Zvereva,
  • Aleksandra Dalina,
  • Igor Blatov,
  • Ilya Zubarev,
  • Daniil Luppov,
  • Alexander Bessmertnyi,
  • Alexander Romanishin,
  • Lamak Alsoulaiman,
  • Vadim Kumeiko,
  • Alexander Kagansky,
  • Gerry Melino,
  • Carlo Ganini,
  • Nikolai A. Barlev

DOI
https://doi.org/10.1186/s13062-021-00307-5
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 21

Abstract

Read online

Abstract During oncogenesis, cells become unrestrictedly proliferative thereby altering the tissue homeostasis and resulting in subsequent hyperplasia. This process is paralleled by resumption of cell cycle, aberrant DNA repair and blunting the apoptotic program in response to DNA damage. In most human cancers these processes are associated with malfunctioning of tumor suppressor p53. Intriguingly, in some cases two other members of the p53 family of proteins, transcription factors p63 and p73, can compensate for loss of p53. Although both p63 and p73 can bind the same DNA sequences as p53 and their transcriptionally active isoforms are able to regulate the expression of p53-dependent genes, the strongest overlap with p53 functions was detected for p73. Surprisingly, unlike p53, the p73 is rarely lost or mutated in cancers. On the contrary, its inactive isoforms are often overexpressed in cancer. In this review, we discuss several lines of evidence that cancer cells develop various mechanisms to repress p73-mediated cell death. Moreover, p73 isoforms may promote cancer growth by enhancing an anti-oxidative response, the Warburg effect and by repressing senescence. Thus, we speculate that the role of p73 in tumorigenesis can be ambivalent and hence, requires new therapeutic strategies that would specifically repress the oncogenic functions of p73, while keeping its tumor suppressive properties intact.

Keywords